The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Pavlov O.N.

Dorozhnaia klinicheskaia bol'nitsa na stantsii Iaroslavl' OAO "RZhD"

Association of the unstable course of coronary heart disease with Helicobacter pylori infection

Authors:

Pavlov O.N.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2012;15(1): 47‑51

Read: 896 times


To cite this article:

Pavlov ON. Association of the unstable course of coronary heart disease with Helicobacter pylori infection. Russian Journal of Preventive Medicine. 2012;15(1):47‑51. (In Russ.)

Recommended articles:
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10

References:

  1. Wyrobiec G., Helewski K., Stepien M. Ischemic heart disease and chronic Helicobacter pylori infection - present views. Wiad Lek 2001; 54: 11-12: 684-692.
  2. Pellicano R., Fagoonee S., Rizzetto M., Ponzetto A. Helicobacter pylori and coronary heart disease: which directions for future studies? Crit Rev Microbiol 2003; 29: 4: 351-359.
  3. Strachan D.P. Non-gastrointestinal consequences of Helicobacter pylori infection. Br Med Bull 1998; 54: 1: 87-93.
  4. Schoecksnadel K., Frick B., Wirleitner C., Winkler C., Schennach H., Fuchs D. Moderate hyperhomocysteinemia and immune activation. Curr Pharm Biotechnol 2004; 5: 1: 107-118.
  5. Strandberg T.E., Tilvis R.S., Vuoristo M., Lindroos M., Kosunen T.U. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997; 314: 7090: 1317-1318.
  6. Patel P., Mendall M.A., Carrington D., Strachan D.P., Leatham E., Molineaux N., Levy J., Blakeston C., Seymour C.A., Camm A.J. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995; 311: 7007: 711-714.
  7. O'Donnell C.J., Levy D. Weighing the evidence for infection as a risk factor for coronary heart disease. Curr Cardiol Rep 2000; 2: 4: 280-287.
  8. Pellicano R., Peyre S., Astegiano M., Oliaro E., Fagoonee S., Rizzetto M. Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease. Panminerva Med 2006; 48: 4: 241-246.
  9. Braunwald E., Jones R.H., Mark D.B. Diagnosing and Managing Unstable Angina. Circulation 1994; 89: 1449-1468.
  10. Ignat'eva T.P., Tuvaleva L.S., Kuramshina O.A. Zabolevaniya zheludochno-kishechnogo trakta kak faktor riska razvitiya ishemicheskoi bolezni serdtsa. Eksp i klin gastroenterol 2004; 1: 122.
  11. Kuimov A.D., Krivosheev A.B., Khvan L.A. Klinicheskie osobennosti yazvennoi bolezni, assotsiirovannoi s IBS. Eksp i klin gastroenterol 2004; 1: 124.
  12. Medvedev V.N., Ivkova I.A., Medvedeva V.N., Ovechkina L.V., Inberg L.M. Diagnostika i lechenie bol'nykh yazvennoi bolezn'yu zheludka v sochetanii s IBS i arterial'noi gipertoniei. Ros gastroenterol zhurn 2001; 2: 136.
  13. Lazebnik L.B., Zvenigorodskaya L.A., Gorunovskaya I.G., Chikunova B.Z., Morozov I.A. Yazvennaya bolezn' u pozhilykh. Eksp i klin gastroenterol 2004; 1: 125.
  14. Krylov A.A. Yazvennaya bolezn' v sochetanii s drugoi patologiei. Klinicheskie proyavleniya, techenie, terapiya. Ter arkh 1992; 2: 121-124.
  15. Rader D.I. Inflommatory markers of coronary risk. N Engl J Med 2000; 326, 343: 1179-1182.
  16. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 432: 12: 836-843.
  17. Kremneva L.V. Leikotsitoz kak pokazatel' riska IBS i ee obostrenii (obzor). Ter arkh 2004; 11: 30-35.
  18. Nasonov E.L. Markery vospaleniya i ateroskleroz: znachenie S-reaktivnogo belka. Kardiologiya 1999; 2: 81-85.
  19. Mash F., Lovis C., Gaspoz J.M., Unger P.F., Bouillie M., Urban P., Rutishauser W. C-reactive protein as a marker for acute coronary syndromes. Eur Heart J 1997; 18: 12: 1897-1902.
  20. Karpov Yu.A., Sorokin E.V., Fomicheva O.A. Vospalenie i ateroskleroz: sostoyanie problemy i nereshennye voprosy. Serdtse 2003; 4: 190-192.
  21. Kul'berg A.Ya. Molekulyarnaya immunologiya. M 1985; 423.
  22. Arutyunov G.P., Kafarskaya L.I., Vlasenko V.K. Mikroflora kishechnika u bol'nykh khronicheskoi serdechnoi nedostatochnost'yu kak vozmozhnyi faktor vozniknoveniya i generalizatsii sistemnogo vospaleniya. Serdechnaya nedostatochnost' 2003; 5: 256-260.
  23. Franceshi F., Roccarina D., Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Minerva Med 2006; 97: 1: 39-45.
  24. Franceshi F., Gasbarrini A. Helicobacter pylori and extragastric diseases. Best Pract Res Clin Gastroenterol 2007; 21: 2: 325-334.
  25. Suzuki H., Marshall B.J., Hibi T. Overview: Helicobacter pylori and extragastric disease. Int J Hematol 2006; 84: 4: 291-300.
  26. Tsaregorodtseva T.M., Serova T.I., Trubitsyna I.E., Klishina M.V., Dubtsova E.A., Lazebnik L.B. Spetsificheskie antitela k Helicobacter pylori pri boleznyakh organov pishchevareniya. Med immunol 2004; 3-5: 346.
  27. Lazebnik L.B., Tsaregorodtseva T.M., Serova T.I., Sokolova G.N., Klishina M.V., Gubina A.V. Antitela k Helicobacter pylori pri boleznyakh zheludka. Ter arkh 2006; 2: 15-19.
  28. Kinjo K., Sato H., Shiotani I., Kurotobi T. et al. Osaka Acute Coronary Insufficiency Study (OACIS) Group Osaka Acute Coronary Insufficiency Study (OACIS) Group. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circulat J 2002; 66: 9: 805-810.
  29. Martines Torres A., Martines Gaensly M. Helicobacter pylori: a new cardiovascular risk factor? Rev Esp Cardiol 2002; 55: 6: 652-656.
  30. Fraser A.G., Scragg R.K., Cox B., Jackson R.T. Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction. Int Med J 2003; 33: 7: 267-272.
  31. Hoffmeister A., Rothenbacher D., Bode G., Persson K., März W., Nauck M.A., Brenner H., Hombach V., Koenig W. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arterioscler Tromb Vasc Biol 2001; 21: 3: 427-432.
  32. Oshima T., Ozono R., Yano Y., Oishi Y., Teragawa H., Higashi Y., Yoshizumi M., Kambe M. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45: 8: 1219-1222.
  33. Cai X.J., Cai H.B., Lu D. Study on the correlation of between infection, inflammation and coronary artery disease. Zhonghua Liu Xing Bing Xue Za Zhi 2003; 24: 6: 503-507.
  34. Zhu J., Quyyumi A.A., Muhlestein J.B., Nieto F.J., Horne B.D., Zalles-Ganley A., Anderson J.L., Epstein S.E. Lack of association of Helicobacter pylori infection with coronary artery disease and frequency of acute myocardial infarction or death. Am J Cardiol 2002; 89: 2: 155-158.
  35. Mayr M., Kiechl S., Mendall M.A., Willeit J., Wick G., Xu Q. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study. Stroke 2003; 34: 3: 610-615.
  36. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 2001; 52: 1: Suppl 1: 3-31.
  37. Yusuf S.W., Mishra R.M. Effect of Helicobacter pylori infection on fibrinogen level in elderly patients with ischaemic heart disease. Acta Cardiol 2002; 57: 5: 317-322.
  38. Grabczewska Z., Nartowicz E. Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis. Przegl Lek 1999; 56: 9: 584-587.
  39. Fraser A.G., Scragg R.K., Cox B., Jackson R.T. Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction. Int Med J 2003; 33: 7: 267-272.
  40. Pellicano R., Parravicini P.P., Bigi R., Gandolfo N., Aruta E., Gai V., Figura N., Angelino P., Rizzetto M., Ponzetto A. Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference? New Microbiol 2002; 25: 3: 315-321

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.